4//SEC Filing
Luehring Jens 4
Accession 0001600132-17-000101
CIK 0001600132other
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 4:56 PM ET
Size
5.4 KB
Accession
0001600132-17-000101
Insider Transaction Report
Form 4
Luehring Jens
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2017-09-22+10,000→ 10,000 totalExercise: $1.12Exp: 2027-09-21→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option was granted on September 22, 2017. This option vests in three equal annual installments over a three-year period from the date of grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001631764
Filing Metadata
- Form type
- 4
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 4:56 PM ET
- Size
- 5.4 KB